ArticleBioengineered2026

Statement of Retraction: Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.